Literature DB >> 19533461

Trans-sylvian transtentorial approach for skull base lesions extending from the middle fossa to the upper petro-clival region.

Sunil K Gupta1.   

Abstract

Various transpetrosal approaches have been described for excision of lesions extending into both the middle fossa and the upper petroclival region. These approaches may be associated with significant morbidity. Six patients with lesions along the medial part of the middle fossa and the upper petroclival region were operated by the trans-sylvian transtentorial approach. The surgical corridor was along the tentorial edge with excision of the tentorium providing adequate access to the tumour without the need for petrosectomy. Three patients had a trigeminal schwanomma, one each had a petroclival meningioma, clival chordoma and an epidermoid tumour. In 5 patients a total/near total excision was achieved while in one patient with petroclival meningioma, a subtotal excision was possible. All patients improved clinically after the surgery. There was no procedure related morbidity. The transsylvian transtentorial approach provides adequate access to upper petroclival lesions allowing the tumours in this region to be removed without the need for a petrosal resection.

Entities:  

Mesh:

Year:  2009        PMID: 19533461     DOI: 10.1080/02688690802716129

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  Quantitative analysis of surgical exposure and surgical freedom to the anterosuperior pons: comparison of pterional transtentorial, orbitozygomatic, and anterior petrosal approaches.

Authors:  Jung-Shun Lee; Alba Scerrati; Jun Zhang; Mario Ammirati
Journal:  Neurosurg Rev       Date:  2016-04-14       Impact factor: 3.042

2.  Elective inferior temporal lobe resection as an adjunct to subtemporal approach for a case of tentorial meningioma arising from the middle part of the free edge of the tentorium: A case report.

Authors:  Sunil Kumar Gupta; Ashish Aggarwal; Lomesh Wankhede
Journal:  Surg Neurol Int       Date:  2020-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.